Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_0600083 |
Description | A reported family history of prostate cancer in one or more family members. | Trait category |
Other trait
|
Mapped terms |
2 mapped terms
|
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS001292 (GBE_FH1044) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Family history of prostate cancer | family history of prostate cancer | 602 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001292/ScoringFiles/PGS001292.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM008958 | PGS001292 (GBE_FH1044) |
PSS004039| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.61052 [0.58828, 0.63276] | R²: 0.03568 Incremental AUROC (full-covars): -0.00159 PGS R2 (no covariates): 0.00029 PGS AUROC (no covariates): 0.5142 [0.49179, 0.53661] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008959 | PGS001292 (GBE_FH1044) |
PSS004040| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.62093 [0.55962, 0.68225] | R²: 0.02796 Incremental AUROC (full-covars): -0.01226 PGS R2 (no covariates): 0.00143 PGS AUROC (no covariates): 0.48253 [0.41865, 0.5464] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008960 | PGS001292 (GBE_FH1044) |
PSS004041| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.56572 [0.5538, 0.57764] | R²: 0.01155 Incremental AUROC (full-covars): 0.01702 PGS R2 (no covariates): 0.00547 PGS AUROC (no covariates): 0.54869 [0.53677, 0.56062] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008961 | PGS001292 (GBE_FH1044) |
PSS004042| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.6064 [0.57694, 0.63587] | R²: 0.02296 Incremental AUROC (full-covars): 0.00822 PGS R2 (no covariates): 0.00335 PGS AUROC (no covariates): 0.54379 [0.5154, 0.57217] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008962 | PGS001292 (GBE_FH1044) |
PSS004043| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Prostate cancer (FH) | — | AUROC: 0.58464 [0.57731, 0.59197] | R²: 0.01828 Incremental AUROC (full-covars): 0.01195 PGS R2 (no covariates): 0.00542 PGS AUROC (no covariates): 0.54716 [0.53996, 0.55435] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS004039 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004040 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004041 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004042 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004043 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |